A detailed history of Douglas Lane & Associates, LLC transactions in Organon & Co. stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 488,304 shares of OGN stock, worth $9.82 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
488,304
Previous 360,775 35.35%
Holding current value
$9.82 Million
Previous $5.2 Million 76.47%
% of portfolio
0.14%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$13.78 - $18.8 $1.76 Million - $2.4 Million
127,529 Added 35.35%
488,304 $9.18 Million
Q4 2023

Jan 17, 2024

SELL
$10.95 - $17.32 $3.02 Million - $4.78 Million
-276,056 Reduced 43.35%
360,775 $5.2 Million
Q3 2023

Oct 16, 2023

BUY
$16.59 - $23.77 $1.41 Million - $2.03 Million
85,218 Added 15.45%
636,831 $11.1 Million
Q2 2023

Jul 19, 2023

BUY
$19.27 - $24.63 $1.65 Million - $2.11 Million
85,846 Added 18.43%
551,613 $11.5 Million
Q1 2023

Apr 17, 2023

SELL
$21.42 - $32.08 $20,520 - $30,732
-958 Reduced 0.21%
465,767 $11 Million
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $13,986 - $17,166
-600 Reduced 0.13%
466,725 $13 Million
Q4 2022

Jan 17, 2023

BUY
$23.31 - $28.61 $5.52 Million - $6.77 Million
236,693 Added 102.63%
467,325 $13.1 Million
Q3 2022

Oct 14, 2022

BUY
$23.4 - $34.25 $699,496 - $1.02 Million
29,893 Added 14.89%
230,632 $5.4 Million
Q2 2022

Jul 18, 2022

SELL
$31.66 - $38.9 $97,671 - $120,006
-3,085 Reduced 1.51%
200,739 $6.78 Million
Q1 2022

Apr 25, 2022

BUY
$30.45 - $39.36 $800,774 - $1.04 Million
26,298 Added 14.81%
203,824 $7.12 Million
Q4 2021

Jan 25, 2022

BUY
$28.67 - $37.13 $1.7 Million - $2.2 Million
59,165 Added 49.99%
177,526 $5.41 Million
Q3 2021

Oct 21, 2021

BUY
$28.63 - $35.64 $1.81 Million - $2.25 Million
63,249 Added 114.76%
118,361 $3.88 Million
Q2 2021

Jul 19, 2021

BUY
$28.45 - $38.0 $1.57 Million - $2.09 Million
55,112 New
55,112 $1.67 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.